Skip to main content

Bad weed: synthetic cannabinoid-associated coagulopathy.

Publication ,  Journal Article
Arepally, GM; Ortel, TL
Published in: Blood
February 28, 2019

Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or "fake weed" highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

February 28, 2019

Volume

133

Issue

9

Start / End Page

902 / 905

Location

United States

Related Subject Headings

  • Immunology
  • Humans
  • Drug Contamination
  • Disease Management
  • Cannabinoids
  • Blood Coagulation Disorders
  • Anticoagulants
  • 4-Hydroxycoumarins
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arepally, G. M., & Ortel, T. L. (2019). Bad weed: synthetic cannabinoid-associated coagulopathy. Blood, 133(9), 902–905. https://doi.org/10.1182/blood-2018-11-876839
Arepally, Gowthami M., and Thomas L. Ortel. “Bad weed: synthetic cannabinoid-associated coagulopathy.Blood 133, no. 9 (February 28, 2019): 902–5. https://doi.org/10.1182/blood-2018-11-876839.
Arepally GM, Ortel TL. Bad weed: synthetic cannabinoid-associated coagulopathy. Blood. 2019 Feb 28;133(9):902–5.
Arepally, Gowthami M., and Thomas L. Ortel. “Bad weed: synthetic cannabinoid-associated coagulopathy.Blood, vol. 133, no. 9, Feb. 2019, pp. 902–05. Pubmed, doi:10.1182/blood-2018-11-876839.
Arepally GM, Ortel TL. Bad weed: synthetic cannabinoid-associated coagulopathy. Blood. 2019 Feb 28;133(9):902–905.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

February 28, 2019

Volume

133

Issue

9

Start / End Page

902 / 905

Location

United States

Related Subject Headings

  • Immunology
  • Humans
  • Drug Contamination
  • Disease Management
  • Cannabinoids
  • Blood Coagulation Disorders
  • Anticoagulants
  • 4-Hydroxycoumarins
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology